iBio Inc (IBIO) Quote

Imagine all the IBIO investors that lost money following his investment advice he posted on this board and others telling people to Buy Buy Buy all without a license to do so.

Maybe on the advice of his attorney he changed his board name to run and hide hoping to dodge any repercussions.

Prolly only a matter of time before fake stock analyst get pulled into a class action.

Here's the really sad part. Had the fake stock analyst invested that $20K equally into the Magnificent 7 stocks (Alphabet/Google, Amazon, Apple, Meta, Microsoft, Nvidia, and Tesla) on July 28, 2020, and reinvested dividends, that $20K investment would now be worth $79,810 today, which is an annual return of 33.42%.

The fake stock analyst would do much better in reputable companies listed on major exchanges, instead of peddling in penny stocks. I imagine that's true for most investors. I've certainly learned my lesson. No more penny stocks for me, EVER.

Results from Portfolio Backtester
https://testfol.io

IBIO conducted 2 reverse splits after JPetro/Rotten Johnny's $20K investment in July 2020.

1-for-25 reverse split on 10/10/22
1-for-20 reverse split on 11/29/23

The 4,000 shares costing $20,000 are now 8 shares valued at $6.32 at the $0.79 closing price.

He's probably still holding these shares at the advice of his attorney. 😂

Daytrade wisely set those stop losses move up to .76 now 

.72 cents and  3.5m shares at .86 on warrants becoming more buyable as GLP-1 without muscle loss is the new  fad in Wegovy Ozempia style weight loss shots. Someone will buy them out if results continue positively 

Rotten Johnny
Tuesday, July 28, 2020

Post# 24016 of 27647
picked up 4k at $5

good to go as this will move North nicely from LOD

How many reverse splits was that ago?

a fool and his money are easily parted

IBIO back in delisting territory. Another great stock pick by the fake analyst, who will certainly be posting "BUY! BUY! BUY!" after IBIO undergoes the 4th reverse split in 7 years.

I wonder if the fake analyst was still invested in Rite Aid when they recently announced their second bankruptcy, where all common stock is cancelled, resulting in 100% loss for common shareholders. On a positive note, his IBIO shares are only down 99.9875% so not a total loss like Rite Aid, and according to his posts he still holds 100% of his AMBS shares from his six-figure investment there. AMBS never did a reverse split, so that loss is only 99.8%.

Where did the fake stock analyst get his investment training? Was he awake or even present during the classes. Probably skipped classes to go surfing, and giving beachgoers a good laugh.

Hey wait a second. The ticker doesn't say $6 something anymore.

The IBIO stock analyst is gonna freak when he finds out the stock lost another 80% since he was last PUMP'n it.

Averaging down prolly was a bad decision for him/her.

iBio Raises $6.2 Million Through Warrant Inducement Transaction

More dilution and if IBIO can't stay above a buckaroo...

Then a 4th RS.

About time for the fake stock analyst to post another BUY BUY BUY recommendation for IBIO. Be sure to ask him about his 99.8% loss in his IBIO shares after 3 reverse splits in the last 7 years.

The stock analyst was giving out BAD financial advice to average down and turns out he is not certified to advise anyone on financial investing.

Wonder some IBIO investors that lost significant money will sue.

Could easily get some of the ambulance chaser companies involved

IBIO printing $0.70

The fake stock analyst is silent. Rest assured if the price rises significantly he will post that he was buying a ton of IBIO shares at this range.

And no one will believe him. If IBIO was such a great buy in the $3 to $6 range, why no posts about buying down here?

Probably because it wouldn't matter. This stock cannot go high enough to recover the 99.9975% losses.

iBIO, new 52 week low

IBIO, new 52;week low

Down almost 10% today.

The poster that was telling everyone to buy the stock without a license to do so should be prosecuted in my opinion and force to pay damages to other shareholders.

Can’t even get a bite of pizza for 1 IBIO share. Glad I didn’t listen to the fool.

IBIO now in delisting territory again. Looks like a 4th reverse split in 7 years is inevitable. I would hate to be an investor who has been loading up on IBIO shares over the last few years... down 99.75% and soon to be down 99.9975%. The ones who post BUY BUY BUY!!

So far the move to NASDAQ is very telling — it couldn't hide the underlying weakness of the company's business model. While being promoted as a move that would enable access to more technically-oriented investors, it appears they have no interest in IBIO, as the stock has steadily declines since the switch to NASDAQ.

Printing $0.98

Image the stock analyst continued to follow his own advice and was averaging down bigly.

Start the delisting clock

Or maybe the reverse split clock

IBIO just broke the $1 barrier and is trading below $1. Lucky for bagholders the board still shows the last $6.33 AMEX price, so everyone can remain optimistic.

"Nothing to see here, folks. No catastrophic losses reported yet. Remain positive until the price feed switches to NASDAQ. Move along."

Down 4% today.

1.16 USD -0.045 (3.75%) today

Maybe the stock analyst still thinks the sp is at $6.33?

Yeah, that's a mistake many rookies and newby investors make, not being able to distinguish between stock purchases in the secondary market, or previously awarded stock options being exercised. With great DD like that, it's no wonder every investment this analyst touches is a disaster leading to catastrophic losses and financial insolvency.

The question is: Can the analyst figure out a way to blame the IBIO CEO for his losses? My bet is YES, based on past behavior that is well documented.

The self proclaimed stock analyst still doesn't know how to read filings

JPetroInc
Friday, February 28, 2025 8:02:16 PM
Post# 27607 of 27631
Form 4's - simply stunning quantity of buys from insiders

https://ih.advfn.com/stock-market/AMEX/ibio-IBIO/news

March 4th is iBio's Nasdaq uplisting

thinking they have major news to announce - on top of the Nasdaq milestone uplisting

Prolly doesn't know about these new fangled things called 'Stock Options' and RSU.

https://ir.ibioinc.com/sec-filings##document-19018-0001104659-25-016298-2
These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.

It's not possible to be down 1000's of percent, as 100% is the maximum when the investment is worth zero. But I certainly understand how it can seem someone is down that much, given the track record.

But considering how long the fake analyst has been buy IBIO shares and how many times those shares have been reduced in the previous three reverse splits, it's a fair guess he is down >99.75%. The analyst might be headed for more catastrophic losses, although I don't recall seeing any posts boasting of six-figure investments in IBIO as in other failed stocks.

Correction... not headed for, as the current share price indicates catastrophic losses have already arrived.

Just wait until IBIO pivots again to another untested strategy, and the fake analyst will enlighten us with many posts about how the future is bright for IBIO and investors should be loading up on shares. Same investment strategy the analyst uses with MONI, and we all know what a loser that is. At least IBIO has/had some revenues and appears to be a legitimate business, although a failing one, where the other investment is clearly an pump-and-dump scam that's easily identified by anyone not stuck as a bag holder of worthless shares. IMO, they're all just pumping it so they can get newbie naive investors to buy their shares. Then, wash - rinse - repeat as they've always done.

When IBIO falls below a buck, they will be forced to do yet another RS.

The fake stock analyst that has been pumping this stock has been 10000% wrong for years.

He claims he always admits when he's wrong, but isn't he down 1000's of percent?

From ChatGPT

IBIO has executed three reverse stock splits in its history:

June 11, 2018 – 1-for-10 Reverse Split
Each 10 shares of common stock were consolidated into 1 share, reducing the outstanding shares from approximately 115.9 million to 11.6 million.

October 10, 2022 – 1-for-25 Reverse Split
Each 25 shares were consolidated into 1 share, decreasing the outstanding shares from about 225.2 million to 9 million.

November 29, 2023 – 1-for-20 Reverse Split
Each 20 shares were consolidated into 1 share, reducing the outstanding shares from approximately 28.1 million to 1.4 million.
During the 2023 reverse split, the authorized number of shares remained unchanged. The company's Certificate of Incorporation was amended solely to effect the reverse stock split without reducing the authorized shares.

Some investors are still buying this TURD even with 3 reverse splits in the last 7 years and looking like another one on the way, given the lack of investor interest in the business model of IBIO since the move from AMEX – last trade at $6.33 – to NASDAQ – last trade at $1.21. Another delisting notice likely on the horizon, followed by yet ANOTHER REVERSE SPLIT to remain listed.

IBIO has turned out to be a terrible investment, so one has to wonder why there has never been any admission of being WRONG, contrary to the BS statement made. In fact, the response to IBIO's continued decline with no real strategy for business success is to continue to BUY BUY BUY!!





In prior failed investments, it's never the investor's fault when they invested six figures in a penny stock with zero revenue or products on the market. Did you ever see one admission of being wrong? I certainly didn't. However, there were about 2,000 posts blaming the CEO for the financial insolvency and catastrophic losses resulting from the investment made.

I have seen posts from other investors who made similar investments and after losing it they did admit their mistake and took responsibility for their decision, and didn't blame the CEO. At least some investors have probably learned from their mistakes and made better decisions going forward.

JPetroInc
Thursday, April 10, 2025
Post# 102492 of 102521
no. I mean what I say, and say what I mean.

I don't have the luxury of time to mince words or leave the room guessing. If I'm wrong, I'll promptly admit it, and then fall on my proverbial sword. That's just how I roll.

Wonder why one without the 'luxury of time' or more hysterical says...

"leave the room guessing"

Never admitted they were wrong when pumping IBIO when the stock with reverse split 1000's of dollars?

All the while pretending to be a stock analyst AND telling investors on this board to BUY BUY BUY without any traning, certifications or licenses to give stock advice.

IBIO printing 1.21

Using simple math...

Lost almost 2/3 in a week.

The IBIO stock analyst is short on time.

I notified IHUB support that the IBIO share price was stuck at $6.33 because it was still trying to pull from AMEX and not Nasdaq. That was weeks ago. I guess fixing it isn't a high priority. Reminds me of IBIO management.

Just checked IBIO share price on Nasdaq... currently at $1.05 and headed lower.

Get ready for a delisting notice and plans for yet another reverse split. I wonder if JPetro is still buying.

How's that IBIO Nasdaq uplist going? Can you tell us what has been "revealed"?

Any insight into the next IBIO reverse split needed in order to remain listed on Nasdaq?

Asking for a friend.

What do you think, Red? Will the next IBIO reverse split to remain listed reduce the authorized shares or keep them the same, as they did before?

How many RS will this be? So many I've lost count.

I've notified IHUB about the issue with the IBIO stock price still pulling from AMEX instead of NASDAQ. Still not fixed. That raised another question... Will the ticker feed be corrected BEFORE the next IBIO reverse split?

Printed: 3.22 USD
-0.58 (15.13%)today

IBIO already lost 1/2 it's value

How much did the pumpers and fake stock analysts load up at?

An IBIO share isn't even worth a slice of crappy pizza.

Maybe get one of those crappy frozen pizzas for the price of an IBIO share

IBIO switching from AMEX to NASDAQ has indeed been VERY REVEALING. 😱 I guess it's not bringing in a lot of investment in the stock as the tale spun by the CEO goes.

Time to LOAD UP, JP. Just make sure there isn't another reverse split in the works. How many is that? 3? 5? More than 5? Will they adjust the authorized share count this time, or leave it unaffected by the RS ratio again and give themselves a blank check for further dilution?

Why is IBIO stock going down?

ChatGPT said:
iBio Inc. (IBIO) has experienced a decline in its stock price due to several factors:?

Public Offering at a Discounted Price: In December 2023, iBio announced a public offering of 2.25 million shares at $2 each, significantly below the prior closing price of $2.70. This offering raised concerns about shareholder dilution, contributing to a 41% drop in stock price at that time.
INVESTORPLACE
?
Reverse Stock Split: In November 2023, the company executed a 20-to-1 reverse stock split, reducing the number of outstanding shares from approximately 28.1 million to 1.4 million. While reverse splits can increase share prices temporarily, they often signal financial distress and can lead to decreased investor confidence. ?

Financial Performance and Cash Flow Concerns: For the fiscal year ending June 30, 2024, iBio reported a net loss of $24.9 million, an improvement from the previous year's loss but still indicative of ongoing financial challenges. The company also faced negative cash flows, raising concerns about its ability to fund operations and growth initiatives. ?

Insider Selling and Dilution Risks: There have been instances of insider stock sales, which can be perceived negatively by investors. Additionally, previous agreements, such as those with Aspire Capital Fund and Lincoln Park Capital Fund, involve the issuance of substantial shares, potentially diluting existing shareholders and impacting stock value. ?

These factors collectively have contributed to the downward pressure on iBio's stock price.

On February 10, 2025 PR they said revenue of $0.2 million was reported for services provided to a collaborative partner during the quarter ended Dec. 31, 2024.

R&D and G&A expenses for the second quarter of fiscal 2025 totaled approximately $4.6 million

Cash, cash equivalents and restricted cash as of Dec. 31, 2024, was approximately $7.2 million, inclusive of $0.2 million of restricted cash.

Lets be generous and add the $650,000 by the members of its Board of Directors and Officers

Why only $650K though for this "Gold Mine".

Was it to give the illusion to save their RSUs and Options?

Using 'simple math' the company had $7.2M in cash in December. Add the $650K

They are currently throwing over $1.5M out the window per month.

That gives the company approximately cash for FIVE months

Jan., Feb. Mar, Apr, May

Who is going to pony up $10M more to keep the boat afloat this year?

Why is iHub still showing AMEX?

Probably because the $6.33 price for the last trade on AMEX is a hell of a lot better than the current $4.50 price on NASDAQ, and IHUB wants to keep IBIO investors from sinking into depression. IBIO share price has been on a steady decline since the move to the new exchange.



Some have posted the move to the NASDAQ exchange would be "revealing", while the company CEO tried to spin it as a positive move for investors. So far it's very revealing.

Perhaps someone is investing another six figures here, loading up on cheaper shares as the price continues lower, assuming they have that much remaining after previous catastrophic investments... clicking the BUY button with one hand while eating a slice of delicious Domino's pizza with the other hand.

Notice the sour look on the investor's face. Even a slice of delicious Domino's pizza can't change the fact they've picked another loser investment, and trying to save face by averaging down as the share price continues to tank. No zip code change in this guy's future.

Another great week of IBIO being "revealed". Here's some encouragement and support for the IBIO investor.

What?

Great to hear from you.

"Your bs is done with IBIO Sir!!!"

I 'do' get why you are responding on Monday, January 20, 2025 12:32:13 AM

to a post I made SIX MONTHS EARLIER on Friday, July 26, 2024 7:57:30 AM LOL

Seems to be a 6 month reaction in hindsight, but I welcome and will return the favor in spaces

where I said...

Toast...

"We are filing this registration statement with the Securities and Exchange Commission (the “SEC”) using a “shelf” registration process. Under this registered “shelf,” in the future, we may, from time to time, sell any combination of the securities described herein, in one or more offerings, up to a maximum aggregate offering price of $150,000,000. This prospectus provides you with a general description of the securities."

Hope spring internal.

Some have invested their kids tuition into IBIO only to send them to maid school.

Risk / Reward

Hey...

Why is iHub still showing AMEX?

iBIO got kicked off AMEX

Booted to the CURB

Surprised the 'stock analyst' that has been promoting this stock since $2000 plus is still trying to still sucker noobs.

I missed all the fun.

Did iBIO get booted off AMEX?

Who didn't see that coming?

What tale is iBIO spinning now?

Love the top spin on how that is a positive.

Only ones going 'all in' are flipping gambler's

For my On Topic post of the day I would suggest iBIO would probably make more money in some kind of Molly Maids gig.
Molly Maid Franchise: Average Sales ($855K) vs. Cost ($133K-$191K)

Maybe iBIO could buy Molly Maids with all the cash on hand they have.

Oh wait...

How much do they have left before they dilute again and do another RS?

Very revealing on Nasdaq, yessiree!! I wonder what next week on Nasdaq will reveal.

Yep! Very revealing. Great launch on the new exchange.

tomorrows 3/4/25 NAS uplisting should be revealing

$iBio

That's great, but your chart is the 6-month chart, not the 52-week chart.

Here's the 52 week IBIO chart, showing the new high isn't that much above the high at the start of the period.




Here's the 2-year IBIO chart.



The 3-year IBIO charts looks even worse.



I hope IBIO can find success this time. There are some posting here who were BUY! BUY! BUYING! shares of IBIO at prices at the much higher prices on these longer-term charts, and will have a long way to go before even remotely breaking even. And the multiple reverse splits haven't helped matters for shareholders.

IBIO, new 52 week high

To be fair, I made the following request to the ChatGPT AI model:

Compare the listing requirements for NYSE American and NASDAQ Capital Markets, including requirements for a company on either exchange to remain listed.

———————————————————————————————
A transfer from NYSE American to NASDAQ Capital Market can be viewed from multiple perspectives, depending on the company's financial situation, growth strategy, and investor perception.

Is It Easier to Meet NASDAQ Capital Market Requirements?

In general, NASDAQ Capital Market has slightly higher requirements than NYSE American in some aspects, such as:

• Stock Price: NASDAQ requires a minimum of $4/share for initial listing, while NYSE American allows as low as $2/share under some standards.

• Stockholders' Equity: NASDAQ requires at least $5 million for initial listing (under the Equity Standard), while NYSE American requires $4–$6 million depending on the listing path.

• Market Capitalization: NYSE American has an initial market cap requirement of $50 million (or lower in alternative standards), while NASDAQ Capital Market has a lower continued listing requirement at $35 million.

If a company is struggling to meet NYSE American's continued listing requirements but still qualifies for NASDAQ Capital Market, the move can help avoid delisting and provide a fresh start on a well-recognized exchange.

How is the Move Perceived?

• Neutral or Positive: If the transfer is due to a strategic decision (e.g., better alignment with NASDAQ’s technology-focused investor base), it may be seen as a neutral or positive move.

• Negative: If the move happens because the company fails to meet NYSE American’s requirements, investors might see it as a downgrade or a sign of financial trouble.

Other Considerations

• NASDAQ has a more tech-friendly reputation: If the company operates in tech, biotech, or growth industries, moving to NASDAQ might attract more institutional and retail investors.

• Market Perception Matters: Investors may view a transfer as an attempt to avoid delisting if the company struggles to meet NYSE American’s standards.

• NASDAQ offers lower listing fees: Annual fees on NASDAQ Capital Market tend to be lower than on NYSE American.

Final Verdict

• If the company voluntarily moves for strategic reasons, it’s a neutral or positive shift.

• If the move is forced due to non-compliance, it may be seen as a negative signal by investors.

• While the requirements aren’t significantly easier, NASDAQ Capital Market does offer a lower continued market cap threshold, which might help struggling companies stay listed.

This is a transfer from NYSE to NASDAQ. Not the same thing as uplisting. NASDAQ's Capital Market requirements are less stringent than NYSE American and easier for IBIO to remain listed on a national exchange. In that regard it could be viewed as a necessary move for the company. The last paragraph below spins it as a positive move, but that's what companies do. Maybe it will be. But no one should be fooled into believing this is an uplisting that occurs when a company is moving to the next higher tier of corporate and financial performance.
March 4th is iBio's Nasdaq uplisting
iBio to Begin Trading on the Nasdaq Stock Exchange

SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio’s common stock has been approved for listing on the Nasdaq Capital Market and iBio will transfer its stock exchange listing to Nasdaq Capital Market from the NYSE American. The Company expects to begin trading as a Nasdaq-listed company on Mar 4, 2025, and will continue to trade under the symbol “IBIO.” The Company’s common stock will continue to trade on the NYSE American until the market close on Mar 3, 2025.

Martin Brenner, Ph.D., DVM, iBio’s CEO and Chief Scientific Officer, commented, “We are pleased to announce our listing on the Nasdaq Capital Market and to join a community of leading biotech companies. We believe the move to Nasdaq will improve the visibility of our common stock, enhance trading liquidity in our shares, and provide us with greater exposure to institutional investors.”

https://ir.ibioinc.com/news-events/press-releases/detail/234/ibio-to-begin-trading-on-the-nasdaq-stock-exchange

Form 4's - simply stunning quantity of buys from insiders

https://ih.advfn.com/stock-market/AMEX/ibio-IBIO/news

March 4th is iBio's Nasdaq uplisting

thinking they have major news to announce - on top of the Nasdaq milestone uplisting

iBIO...!

IBIO $5.68 coming to the rescue so munch for Chinese take out.. Bird Flu in Cats New Jersey
Two domestic cats in New Jersey have tested positive for the highly pathogenic avian influenza (H5N1) in Hunterdon County. One feral cat developed severe disease, including neurologic signs, and was euthanized. Another indoor-outdoor cat also tested positive, and tests on other cats on the property are pending.Additional Details:Symptoms in Cats: Clinical signs of bird flu in cats can include respiratory signs (discharge from the eyes and mouth, sneezing, coughing, difficulty breathing) and neurologic signs.Transmission: Cats can contract the virus through exposure to infected birds or other animals, contaminated environments, or by consuming raw/undercooked meat or milk from infected sources.Prevention: Pet owners are advised to avoid feeding cats raw milk or meat, avoid contact with sick or dead birds and wildlife, and thoroughly wash hands and change clothes after handling sick animals.Human Risk: While the risk of H5N1 infection to the general population remains low, close contact with infected animals can pose a risk. No human cases have been reported in New Jersey.Reporting: New Jersey residents should contact their veterinarian if they have concerns about their pets. Suspect feline cases should be reported to the New Jersey Department of Health at 609-826-4872 or zoonoticrn@doh.nj.gov.

IBIO $5.60 to the moon ...lol New Jersey domestic cats caight the bird 🦅 flu...$TRAW $GOVX $IBIO
Eggs to the moon 🥚 

All in last couple months.... interesting 

Good luck with IBIO. I hope when it reaches $1,000/share you will have recovered all of your prior losses in this turd.